Skip to main content

Management of Patients with Posterior Uveal Melanoma

  • Chapter
  • First Online:
  • 806 Accesses

Abstract

The management of patients with posterior uveal melanoma involves detection, examination, treatment, prognostication, counseling, and surveillance (Box 12.1). Each of these activities is advancing rapidly, thanks to technological developments as well as a better understanding of tumor biology.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2384 patients. Ophthalmology. 2012;119:1582–9.

    Article  PubMed  Google Scholar 

  2. Bove R, Char DH. Nondiagnosed uveal melanomas. Ophthalmology. 2004;111(3):554–7.

    Article  PubMed  Google Scholar 

  3. Eskelin S, Kivela T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol. 2002;86(3):333–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Damato BE. Tumour fluorescence and tumour-associated fluorescence of choroidal melanomas. Eye (Lond). 1992;6(Pt 6):587–93.

    Article  Google Scholar 

  5. Callejo SA, Dopierala J, Coupland SE, Damato B. Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol. 2011;129(7):958–60.

    Article  PubMed  Google Scholar 

  6. Sen J, Groenewald C, Hiscott PS, Smith PA, Damato BE. Transretinal choroidal tumor biopsy with a 25-gauge vitrector. Ophthalmology. 2006;113(6):1028–31.

    Article  PubMed  Google Scholar 

  7. Feinstein EG, Marr BP, Winston CB, Abramson DH. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Arch Ophthalmol. 2010;128(3):319–23.

    Article  PubMed  Google Scholar 

  8. Damato B, Heimann H. Personalized treatment of uveal melanoma. Eye (Lond). 2013;27(2):172–9.

    Article  CAS  Google Scholar 

  9. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111(5):977–83.

    Article  PubMed  Google Scholar 

  10. Stannard C, Sauerwein W, Maree G, Lecuona K. Radiotherapy for ocular tumours. Eye (Lond). 2013;27(2):119–27.

    Article  CAS  Google Scholar 

  11. Russo A, Laguardia M, Damato B. Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2012;250:1533–40.

    Article  PubMed  Google Scholar 

  12. Astrahan MA, Luxton G, Jozsef G, Kampp TD, Liggett PE, Sapozink MD, et al. An interactive treatment planning system for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18(3):679–87.

    Article  CAS  PubMed  Google Scholar 

  13. Daftari IK, Char DH, Verhey LJ, Castro JR, Petti PL, Meecham WJ, et al. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys. 1997;39(5):997–1010.

    Article  CAS  PubMed  Google Scholar 

  14. Damato BE, Groenewald C, Foulds WS. Surgical resection of choroidal melanoma. In: Ryan SJ, editor. Retina. 5th ed. London: Elsevier; 2013. p. 2298–306.

    Chapter  Google Scholar 

  15. Konstantinidis L, Groenewald C, Coupland SE, Damato B. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Br J Ophthalmol. 2014 Feb 25. doi: 10.1136/bjophthalmol-2013-304501. [Epub ahead of print].

    Google Scholar 

  16. Schilling H, Bornfeld N, Talies S, Anastassiou G, Schuler A, Horstmann GA, et al. [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife–first experience on 46 cases]. Klin Monbl Augenheilkd. 2006;223(6):513–20.

    Article  CAS  PubMed  Google Scholar 

  17. Journee-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM, de Wolff-Rouendaal D. Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol. 1992;82(3):185–91.

    Article  CAS  PubMed  Google Scholar 

  18. Shields CL, Shields JA, Perez N, Singh AD, Cater J. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002;109(2):225–34.

    PubMed  Google Scholar 

  19. Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye (Lond). 2013;27(2):163–71.

    Article  CAS  Google Scholar 

  20. Barbazetto IA, Lee TC, Rollins IS, Chang S, Abramson DH. Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol. 2003;135(6):898–9.

    Article  PubMed  Google Scholar 

  21. Wilson DJ, Klein ML. Cryotherapy as a primary treatment for choroidal melanoma. Arch Ophthalmol. 2002;120(3):400–3.

    PubMed  Google Scholar 

  22. Konstantinidis L, Groenewald C, Coupland SE, Damato B. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol. 2014;98(1):82–5.

    PubMed  Google Scholar 

  23. Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol. 2008;92(8):1013–4.

    Article  PubMed  Google Scholar 

  24. Bechrakis NE, Foerster MH. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin. 2006;46(1):95–107.

    PubMed  Google Scholar 

  25. Kujala E1, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, Kivelä T. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol. 2013;31(22):2825–31.

    Google Scholar 

  26. Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285–95.

    Article  PubMed  Google Scholar 

  27. Marshall E, Romaniuk C, Ghaneh P, Wong H, McKay M, Chopra M, et al. MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. Br J Ophthalmol. 2013;97(2):159–63.

    Article  PubMed  Google Scholar 

  28. Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivelä T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85(5):1151–9.

    Article  CAS  PubMed  Google Scholar 

  29. Wen JC, Sai V, Straatsma BR, McCannel TA. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma. JAMA Ophthalmol. 2013;131(1):56–61.

    Article  PubMed  Google Scholar 

  30. Patel P, Finger PT. Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis. Am J Ophthalmol. 2012;153(4):661–8.

    Article  PubMed  Google Scholar 

  31. Strobel K, Bode B, Dummer R, Veit-Haibach P, Fischer DR, Imhof L, et al. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging. 2009;36(11):1774–82.

    Article  CAS  PubMed  Google Scholar 

  32. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22(12):2438–44.

    Article  PubMed  Google Scholar 

  33. Augsburger JJ, Correa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011;152(1):5–9 e1.

    Article  PubMed  Google Scholar 

  34. Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010;128(7):871–5.

    Article  PubMed  Google Scholar 

  35. Whitehead J, Tishkovskaya S, O’Connor J, Damato B. Devising two-stage and multistage phase II studies on systemic adjuvant therapy for uveal melanoma. Invest Ophthalmol Vis Sci. 2012;53(8):4986–9.

    Article  CAS  PubMed  Google Scholar 

  36. Ah-Fat FG, Sharma MC, Damato BE. Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy. Eye (Lond). 1998;12(Pt 5):789–91.

    Article  Google Scholar 

  37. Damato B, Heiman H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma. Tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2014.77. Published online March 13,2014.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bertil Damato MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Damato, B. (2014). Management of Patients with Posterior Uveal Melanoma. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54255-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54255-8_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54254-1

  • Online ISBN: 978-3-642-54255-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics